BUPIVACAINE HCL-LIORESAL PF INJECTABLE 7 recalled over sterility concerns
- Recall date
- October 5, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Med Shop Total Care Inc. recalls BUPIVACAINE HCL-LIORESAL PF INJECTABLE 7.5MG-1625MCG/ML, 41 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281…
- Recall number
- D-0705-2021
- FDA classification
- Class I
- Brand / firm
- Med Shop Total Care Inc.
- Sold / distributed
- Texas and Puerto Rico
Why it was recalled
Non-Sterility
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
BUPIVACAINE HCL-LIORESAL PF INJECTABLE 7.5MG-1625MCG/ML, 41 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605
Get recall alerts
Free email alert whenever Med Shop Total Care Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Med Shop Total Care Inc.